Key Points Pfizer is a large drugmaker with a strong history of working through difficult periods. The pharmaceutical giant's challenges include facing down an impending patent cliff. Pfizer's dividend payout ratio is worryingly high, potentially putting the dividend at risk. 10 stocks we like better than Pfizer › The big draw for most investors with Pfizer (NYSE: PFE) today is likely to be its lofty 7.2% dividend yield. That compares to 1.2% for the S&P 500 index and about 1.3% for the average p ...